CATALIS Québec is a non-profit organization whose governance relies on a network of public and private partners to carry out its mission and vision of operational improvement and excellence in clinical research in Quebec. The Advisory Committee plays an advisory role by supporting the executive management team in implementing the strategic plan and any priority actions approved by the board of directors.

Board of Directors

Marc Rivière MD

Chairman
General Partner & CMO,
TVM Capital Life Sciences

Diane Gosselin PhD, MBA, ASC

President & CEO
CQDM

Monique Lacroix

Country Head, Global Development Operations / Trial Monitoring
Novartis Pharmaceuticals Canada Inc.

Jefferson Tea PhD, MBA

Vice-President, Medical & Scientific Affairs
Takeda Canada Inc.

Jacques Michaud MD

Director
Centre de recherche CHU Ste-Justine

Louise Proulx PhD, ICD.D

Corporate Director

Micheal Sebag

Michael Sebag MD

Hematologist
Research Institute – McGill University Health Centre (RI-MUHC)

Observer Members

Martin Doyon ing. PhD

Director, Networking and Industrial Partner Direction
Ministry of the Economy and Innovation of Quebec

Julie Couture

Director of Data Quality, Research and Internal Coordination
Minister of Health and Social Services (MSSS)

Guests

François Painchaud

Corporate Secretary
Partner
Robic

Paul Lohnes

Treasurer, Director of Finance and Administration and Assistant Corporate Secretary
CATALIS Québec

Operations Committee

Josée LeclercM.Sc., DESS

Senior Manager, Clinical Research
University of Montreal Hospital Research Centre (CRCHUM)

Cinzia Raponi CPA, CMA

Director, Administration
Research Institute McGill University Health Centre (MUHC)

Sylvie Cossette CPA, CA

Associate Director of Research
CHU Sainte-Justine

Annie Morin PhD

Interim Assistant Scientific Director
Centre de recherche du CHUS (CRCHUS) CIUSSS de l’Estrie – CHUS

Stéphane Bolduc MD FRCSC

Deputy-Director of clinical research
CHU de Québec – Université Laval

Chantal Lacasse PhD

Senior Clinical Operations Manager, Clinical Research
AbbVie Corporation

Pascale Landry PhD

Senior Clinical Research Associate, Clinical Research, Global Medical Division
GSK Canada

Jacqueline Atallah B.Pharm.

Director Clinical Site Management
Pfizer

Marie-France Goyer

Therapeutic Area Head, Merck

Jefferson Tea PhD, MBA

Vice-President, Medical & Scientific Affairs
Takeda Canada Inc.

Lucie d’AmoursB.A.A.

General Manager, Q-CROC

George Memari B.Sc.

Budget and Contract Manager
Novartis

David Senac Eng.

Country Study Manager, Country Clinical Operations
Hoffmann-La Roche Limited (Roche Canada)

Dominique Johnson PhD

General Manager, McPeak Sirois Group

Isabelle Voccia Ph.D

Therapeutic Area Specialist-oncology and immunology
Manager, Clinical trial portfolio
Boehringer Ingelheim

Jean-François Leger M.Sc.

Site Partnership Manager, Sanofi Canada

Yvon Fréchette Chemist, M.Sc.

Innovation Advisor, Collaborative Research Direction
Ministry of the Economy and Innovation of Quebec

Julie Couture

Director of Data Quality, Research and Internal Coordination
Minister of Health and Social Services (MSSS)

Jenny Kaeding Ph.D

Ethics Advisor, Research and Internal Coordination
Minister of Health and Social Services (MSSS)

Nadine Gagnon

Research Coordination Advisor, Research and Internal Coordination
Minister of Health and Social Services (MSSS)

Danika Laberge PMP

General Manager
CATALIS Québec

Scientific Advisory Committee

Dr. Angela Genge Chair

Neurologist and Director, Clinical Research Unit

Montreal Neurological Institute and Hospital

Dr. John Mitchell

Pediatric Endocrinologist

Research Institute of the McGill University Health Centre (RI-MUHC)

Dr. Rahima Jamal 

Hemato-oncologist and Director of the Unit for Innovative Therapies

University of Montreal Hospital Research Centre (CRCHUM)

Dr. Michael Sebag

Hematologist, Research Institute

McGill University Health Centre (RI-MUHC)

Dr. Maxime Chénard-Poirier

Hematologist and Oncologis

CHU de Québec-Université Laval Research Center

Dr. Jean-Claude Tardif

Director

Montreal Heart Institute Research Center

Scientific Director, Montreal Health Innovations Coordinating Centre (MHICC)

Dr. Jean-Philippe Lafrance

Nephrologist

Maisonneuve-Rosemont Hospital Research Centre

Associate Professor, Department of Pharmacology and Physiology Université de Montréal

Dr. Michel Duval

Head of the Hematology-Oncology Department and clinical researcher

CHU Sainte-Justine Research Center

Dr. Wilson H. Miller

Director, Clinical Research Unit

Jewish General Hospital, Lady Davis Institute for Medical Research

Dr. André Carpentier

Director of the Diabetes, Obesity and Cardiovascular Complications Research Axis

Centre for Research at the CHUS (CRCHUS) – Université de Sherbrooke

Management team

Jacques Hendlisz

Jacques Hendlisz

Executive President of CATALIS Québec
Jacques Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to 2011 and as Director of Operations of the Goodman Cancer Research Centre from 2011 to 2012. Since 2003, Mr. Hendlisz has served on numerous boards of directors such as those of the McGill Centre for the Convergence of Health and Economics, Research Canada, the Ludmer Foundation, the Graham Boeckh Foundation, and the Fonds de recherche Québec – Santé (FRQS) (from 2004 to 2010). He is currently Chairman of the MNI’s Clinical Research Unit’s Advisory Board.  Jacques is committed and determined to gather all the actors involved in clinical research to accelerate the development of innovative patient care.

Danika Laberge PMP

General Manager of CATALIS Québec
Danika Laberge has over twenty years of experience working in the biopharmaceutical industry and in institutional settings. As a senior project manager with Project Management Professional (PMP) accreditation, she has headed numerous projects, including the Quebec CARTaGENE biobank, where she was the director of clinical operations. Between 2010 and 2017, Danika was in charge of operations at the McConnell Centre for Innovative Medicine at the Research Institute of the McGill University Health Centre, a centre specializing in clinical trial management. Danika Laberge helps CATALIS achieve its desired objectives by means of her thorough knowledge of the Quebec clinical research environment, her approach focused on operational excellence, her leadership and her qualities as a manager able to motivate actors in the life science industry.

Paul Lohnes CPA, CA

Director Finance and Administration of CATALIS Québec
Paul Lohnes is a senior executive with over 40 years of experience in professional services organizations in Canada. His credentials include: audit and professional practice as a partner with KPMG in Montreal and The Netherlands; senior roles in audit standard-setting and audit regulation and quality control; and chief executive of a not-for-profit organization in the public sector. In addition to financial and audit acumen, he brings to CATALIS expertise in governance and human resources management. Paul has a keen interest in healthcare research and in contributing to achieving CATALIS’ mission. He is currently Copresident of the Board of the Quebec Association of Myalgic Encephalomyelitis (M.E.), a member of the executive committee of the Interdisciplinary Canadian Collaborative M.E. Research Network (ICanCME), and on the Board of NOVA Hudson.

Olivier Jérôme

Director, public and patient engagement of CATALIS Québec
With over ten years of professional experience in the general and operational management of health organizations, Olivier Jérôme has overseen various mandates that focused on patients and their family caregivers. A seasoned administrator in the organizational development and operationalization of health programs, he has actively participated in creating, reorganizing, and expanding the units he was responsible for, including those in reproductive medicine, obstetrics, oncology, and rare diseases. Olivier also has a comprehensive understanding of the political environment and governmental affairs in health at the federal and provincial levels. He will use this expertise to benefit patients and family caregivers by facilitating and accelerating access to innovative health treatments. He joins the CATALIS team with a passion for both research and access to innovation in health care and will undoubtedly contribute to the success of its mission.

Maria Fraraccio

Project Manager – CATALIS Québec
With more than fifteen years of experience in internationally renowned Quebec institutes and research centers, Maria has led numerous phase II to IV clinical trials in various therapeutic fields and has extensive operational expertise more specifically in the processes related to feasibility, budget development and negotiation, and submissions for the triple review, namely science, ethics and institutional conformity. Supported by extensive knowledge of ICH GCP guidelines, Health Canada regulations and ministerial standards, she specializes in the development and support of clinical research activities, as well as coordination with the various key players to achieve clinical research targets and maximum performance.

As Project Manager, Maria will be responsible for the implementation of the new FAST TRACK review service. She will have the pleasure of working and supporting a network of committed and dedicated members who are all devoted to optimizing and accelerating the accessibility of clinical trials in Quebec.